Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
  • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
  • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
  • C07D239/56—One oxygen atom and one sulfur atom
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/08—Bronchodilators
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
  • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
  • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
  • C07D239/52—Two oxygen atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
  • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
  • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
  • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Engineering & Computer Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Epidemiology (AREA)
• Pulmonology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=22715935

Family Applications (1)

Country Status (25)

Families Citing this family (7)

Family Cites Families (2)

• 0
  • BE BE790125D patent/BE790125A/en not_active IP Right Cessation
• 1972
  • 1972-02-18 GB GB774872A patent/GB1377308A/en not_active Expired
  • 1972-02-18 GB GB5005373A patent/GB1377720A/en not_active Expired
  • 1972-09-25 SE SE7212358A patent/SE393376B/en unknown
  • 1972-09-28 AU AU47228/72A patent/AU467600B2/en not_active Expired
  • 1972-09-28 IL IL40458A patent/IL40458A/en unknown
  • 1972-10-02 PH PH13959A patent/PH10129A/en unknown
  • 1972-10-05 DE DE2264657A patent/DE2264657C2/en not_active Expired
  • 1972-10-05 DE DE2264374A patent/DE2264374C3/en not_active Expired
  • 1972-10-05 DE DE2248741A patent/DE2248741C3/en not_active Expired
  • 1972-10-06 AT AT00933/74A patent/AT320656B/en not_active IP Right Cessation
  • 1972-10-06 AT AT858972A patent/AT321308B/en not_active IP Right Cessation
  • 1972-10-12 YU YU2551/72A patent/YU35125B/en unknown
  • 1972-10-12 FI FI2825/72A patent/FI55503C/en active
  • 1972-10-13 NO NO3686/72A patent/NO136574C/en unknown
  • 1972-10-13 SU SU1839308A patent/SU498908A3/en active
  • 1972-10-16 NL NL7213959.A patent/NL166470C/en not_active IP Right Cessation
  • 1972-10-16 CH CH165674A patent/CH549579A/en not_active IP Right Cessation
  • 1972-10-16 CH CH1507872A patent/CH555832A/en not_active IP Right Cessation
  • 1972-10-16 DK DK510072AA patent/DK131465B/en not_active IP Right Cessation
  • 1972-10-16 ZA ZA727362A patent/ZA727362B/en unknown
  • 1972-10-16 FR FR7236560A patent/FR2157865B1/fr not_active Expired
  • 1972-10-16 PL PL1972174103A patent/PL89852B1/pl unknown
  • 1972-10-16 CA CA153,956A patent/CA980778A/en not_active Expired
  • 1972-10-16 PL PL1972158297A patent/PL84634B1/pl unknown
  • 1972-10-16 JP JP10279972A patent/JPS5337870B2/ja not_active Expired
  • 1972-10-16 LU LU66304A patent/LU66304A1/xx unknown
  • 1972-10-16 IE IE1398/72A patent/IE37043B1/en unknown
  • 1972-10-18 ES ES407730A patent/ES407730A1/en not_active Expired
  • 1972-10-19 EG EG431/72A patent/EG11013A/en active
  • 1972-10-23 AR AR244763A patent/AR198798A1/en active
• 1973
  • 1973-07-12 AR AR249053A patent/AR196263A1/en active
• 1974
  • 1974-03-26 SU SU2008490A patent/SU505362A3/en active
• 1975
  • 1975-04-15 ES ES436624A patent/ES436624A1/en not_active Expired
  • 1975-05-06 SE SE7505279A patent/SE397090B/en unknown
  • 1975-11-21 PH PH17784A patent/PH11594A/en unknown
• 1976
  • 1976-01-05 IL IL48790A patent/IL48790A/en unknown
• 1978
  • 1978-02-08 JP JP1336078A patent/JPS53116386A/en active Granted
• 1979
  • 1979-04-25 YU YU991/79A patent/YU36295B/en unknown

Also Published As

Similar Documents